Published in Vaccine Weekly, December 9th, 1996
This situation likely will require postmarketing surveillance to collect data formerly provided by large-scale trials, predict Pierre Begue and Emmanuel Grimprel of the Armand-Trousseau Children's Infectious and Tropical Disease Hospital, Paris, France.
Begue and Grimprel considered the implications of new vaccine combinations in The Journal of Infectious Diseases ("Future Combined Vaccines," JID, 174(Suppl 3):S295-7).
"Because of the growing number of new vaccines to be included in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly